Schuth Alexander O.

CIK 00017243111 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001724311

Recent Transactions

50 trades

Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2026-01-06$16.50/sh−17,218→ 282,828 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2026-01-03+57,700→ 300,046 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2026-01-03+173,100→ 173,100 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-08-12$13.58/sh−2,937→ 242,346 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-07$20.81/sh−2,907→ 244,308 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-06$20.22/sh−12,255→ 247,215 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-03+54,180→ 259,470 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-01-03+162,540→ 162,540 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-12-27$5.28/sh+6,708→ 205,290 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-12-27−6,708→ 46,671 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-11-22−20,516→ 124,562 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-22$0.68/sh+20,516→ 198,582 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-11-07−15,558→ 53,379 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-07$29.68/sh−12,333→ 181,291 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-07$5.28/sh+15,558→ 193,624 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-07$30.72/sh−2,925→ 178,366 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-07$31.29/sh−300→ 178,066 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-21$24.78/sh−2,547→ 178,066 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-20$23.54/sh−3,353→ 180,613 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-20$23.79/sh−2,453→ 183,966 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-13$22.89/sh−2,272→ 186,419 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-14$17.66/sh−20,128→ 187,341 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-13$17.29/sh−2,716→ 207,469 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-02-08−50,000→ 145,078 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-08$0.68/sh+50,000→ 210,185 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-05$19.43/sh−9,972→ 539,307 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-03+53,720→ 170,157 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-01-03+161,160→ 161,160 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-23$23.17/sh−2,522→ 518,989 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-21$22.59/sh−2,478→ 521,511 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-14$23.67/sh−2,772→ 518,989 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-10$24.18/sh−2,853→ 521,761 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-07-18$30.01/sh−9,702→ 518,989 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-07-17−10,000→ 68,937 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-07-17$5.28/sh+10,000→ 538,691 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-07-17$29.60/sh−10,000→ 528,691 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-05-15$5.28/sh+10,000→ 538,691 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-05-15$29.23/sh−800→ 528,691 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-05-15$28.55/sh−9,200→ 529,491 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-05-15−10,000→ 78,937 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-04-13−4,898→ 88,937 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-13$5.28/sh+4,898→ 533,589 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-13$25.04/sh−4,898→ 528,691 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-12$25.04/sh−5,102→ 528,691 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-04-12−5,102→ 93,835 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-04-12$5.28/sh+5,102→ 533,793 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-02-13−25,000→ 195,078 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$0.68/sh+25,000→ 524,902 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$30.09/sh−3,497→ 528,691 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-08$30.89/sh−1,521→ 499,902 total

Companies

Denali Therapeutics Inc.
COFO and Secretary
$DNLI

Recent Filings

Address

C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov